This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Leading pharmaceutical outsourcing provider PCI Pharma Services is delighted to announce the promotion of Brian Keesee to the new position of Vice President and General Manager, Global Clinical Operations and Supply. Keesee’s appointment demonstrates PCI’s ongoing investment in its first-class Clinical Services offering; this new role reflects the continued growth of this significant division of the PCI Pharma Services business, and is in direct response to customer requirements.
Based at PCI’s Rockford, IL Clinical center of excellence, Brian will oversee PCI’s various Clinical departments and execute the strategic plan to evaluate, improve and bring further harmonization to its wider operations, reflecting the organization’s commitment to offering full-service solutions to its clients globally, irrespective of where a project is delivered. He will drive overall project management, overseeing storage and distribution services, quality control and operation of the business to ensure the clinical team continues to achieve their number one commitment of delivering exceptional customer service for PCI’s clients across the world.
Commenting on Brian’s promotion, PCI Senior Vice President Global Operations, Brad Payne said: “We are delighted to have Brian in this new role, which is warranted due to the significant growth of our Clinical Services business globally. This position will ensure global oversight and harmonization of our Clinical operations and supply functions. His significant experience and skills will serve the business well; driving and supporting the sales strategy, new opportunities, project management and team development in his leadership of this important function.”
Brian added: “Our Clinical Services division is a significant part of the existing PCI business and targeted growth area. We have a group of amazing people, which I am excited to be leading. I will be overseeing strategy development, working to solve business challenges, improving programs and technologies across the division to demonstrate a harmonized “One PCI” Clinical experience business to our clients around the world.”
PCI continues to make considerable investment across its global Clinical supply business, recently announcing the opening of a new building at its Bridgend, UK European Center of Excellence. In addition, PCI announced the acquisition of Australian based PPP, specializing in expediting of Phase I clinical study in the Australian and Asia Pacific region, significantly expanding PCI’s global reach and market access.
